Featured
Announcements
-
-
-
-
Nature Aging on PubMed
Advertisement
-
-
An emerging biomarker for dopaminergic cell loss
A recent publication in Nature Aging suggests that DOPA decarboxylase may serve as an emerging biomarker that can identify neurodegenerative disorders that are characterized by dopaminergic cell loss. Here we discuss how this finding can assist clinicians and researchers in the differential diagnosis of individuals who present with parkinsonism or cognitive decline.
-
-

Aging, longevity and age-related diseases
Our understanding of the biology of aging and longevity has grown tremendously over the past two decades.
Trending - Altmetric
-
Multi-omic rejuvenation and lifespan extension on exposure to youthful circulation
-
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease
-
APOEε4 potentiates amyloid β effects on longitudinal tau pathology
-
Longitudinal Aging Study in India (LASI): new data resources for addressing aging in India